Search
Search Constraints
You searched for: Author/Creator Hickling, Julian- Hickling, Julian [remove] 5
- 615.372 5
- Vaccines -- Periodicals 5
- ADCC Antibody-dependent cell-mediated cytotoxicity -- AE Adverse event -- CMI cell-mediated immunity -- CONSISE Consortium for the Standardization of Influenza Seroepidemiology -- CoP Immune correlate of protection -- EMA European Medicines Agency -- EU European Union -- HA Influenza haemagglutinin protein -- HI Haemagglutination inhibition -- Hib Haemophilus influenzae type b -- HICs High-income countries -- IIV Inactivated influenza vaccine -- LAIV Live-attenuated influenza vaccine -- LMICs Low- and middle-income countries -- M2e Ectodomain of influenza matrix 2 protein -- NA Influenza neuraminidase protein -- PDVAC WHO Product Development for Vaccines Advisory Committee -- PPC Preferred product characteristic -- PPP Public-private partnerships -- WHO World Health Organization 1
- ADCC antibody-dependent cell-mediated cytotoxicity -- CMI cell-mediated immunity -- COBRA computationally optimized broadly reactive antigen -- CoP immune correlate of protection -- HA influenza haemagglutinin protein -- HI haemagglutination inhibition -- IFN interferon -- IgA immunoglobulin A -- LAIV live attenuated influenza vaccines -- M1 influenza matrix protein 1 -- M2e ectodomain of influenza matrix protein 2 -- MVA modified vaccinia Ankara -- NA influenza neuraminidase protein -- NHP non-human primates -- NP influenza nucleoprotein -- PB1 polymerase basic 1 protein -- PH1N1 2009 influenza pandemic virus -- TFH T-follicular helper cells -- TIV trivalent influenza vaccines -- VLP virus-like-particle -- WHO World Health Organization 1
- CTC controlled temperature chain -- LMIC low- and middle-income country -- MAP microarray patch -- UNICEF United Nations Children's Fund -- VIPS Vaccine Innovation Prioritisation Strategy -- WHO World Health Organization 1
- Coverage and equity -- Low- and middle-income countries -- Vaccine Innovation Prioritisation Strategy -- Vaccine product innovations 1
- Immunization -- Global health -- Ageing -- Immune senescence, World Health Organization -- Vaccine development 1
- Influenza -- Pandemic influenza vaccine -- Seasonal influenza vaccine -- Universal influenza vaccine -- Vaccine development -- Nextgeneration influenza vaccine 1
- Influenza -- Vaccine -- Pandemic influenza vaccine -- Universal influenza vaccine -- H7N9 vaccine -- Seasonal influenza vaccine 1
- Microarray patch -- Microneedle patch -- Nanopatch -- Transcutaneous vaccination -- Influenza -- Clinical trial 1